Improving medication adherence in adolescents with lupus using personalized feedback
Official title: Direct-to-family pharmacokinetics intervention for hydroxychloroquine non-adherence in adolescents with systemic lupus erythematosus
Funded at Duke University · NIH-10928505 · Data updated 2026-11-12
This study is looking to help teenagers with lupus take their medicine regularly by creating a digital tool that shows them how their medication works in their body, making it easier for them to understand why it's important to stick to their treatment plan.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $158,652 |
| NIH project number | 1K23AR084424-01 |
| Project ID | NIH-10928505 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adolescents diagnosed with pediatric systemic lupus erythematosus who struggle with medication adherence.
✕Less likely to help
Patients who are not adolescents or those without a diagnosis of pediatric systemic lupus erythematosus may not benefit from this research.
What this research studies
This research focuses on addressing the issue of medication non-adherence among adolescents with pediatric systemic lupus erythematosus (pSLE), particularly regarding the use of hydroxychloroquine (HCQ). The study aims to develop a digital intervention that provides personalized feedback based on pharmacokinetic simulations, helping patients understand their medication levels and encouraging them to take their medication as prescribed. By identifying a specific concentration cutoff for HCQ, the research seeks to create a reliable method for detecting non-adherence in clinical settings. The intervention will be tested for feasibility and preliminary effectiveness in a small group of adolescents, paving the way for larger trials in the future.
Why it matters
Potential benefit: If successful, this research could significantly improve medication adherence and health outcomes for adolescents with lupus.
How similar studies have gone: Previous research has shown promise in using digital interventions to improve medication adherence, suggesting that this approach could be effective.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Randell, Rachel Leigh — Duke University
- Study coordinator: Randell, Rachel Leigh
Related research
Other NIH-funded projects on the same topics.
-
Immunostimulatory short non-coding RNAs and lupus
A study in people with lupus looks at tiny RNA pieces that may spark inflammation, to understand if they drive disease activity.
-
Antiviral factors that limit HIV in people with SLE
Researchers at Howard University are studying how immune factors in people with lupus may help limit HIV infection.
-
Mechanistic clues about lupus from immune disorders
This grant looks at why certain immune disorders in people with genetic immune problems lead to lupus-like symptoms, by studying patients and mouse models.
-
Subjective thinking challenges in adults with lupus as they age
This grant aims to understand how lupus-related cognitive problems affect adults, especially older adults, and tests a real-time method to track daily fluctuations in those symptoms.
-
Mitochondrial targets of antibodies in lupus (SLE)
A Johns Hopkins-led study will identify which mitochondrial membrane proteins are targeted by autoantibodies in lupus patients to understand how these immune attacks fuel the disease.
-
Influenza, Hydroxychloroquine, and the Windows of Self-Peptide Presentation in Lupus
A doctor-researcher is studying how flu infection and the lupus medication hydroxychloroquine change the way the immune system shows self-parts to trigger or prevent lupus flares in kids.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.